Vitrolife AB (VITR.ST)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|60||2013||Independent Chairman of the Board|
|59||2017||Chief Executive Officer|
|41||2017||Chief Financial Officer|
|46||2015||Vice President Market Region EMEA & Americas|
|45||2012||Vice President Business Development & Global Communications|
- BRIEF-Vitrolife hikes dividend, Q4 EBITDA up yr/yr
- BRIEF-Vitrolife says Embryoscope approved for sales in China
- BRIEF-Vitrolife buys licensing rights for embryo transfer technology
- BRIEF-William Demant fund raises stake in Vitrolife to 21.6 pct
- BRIEF-Vitrolife Q3 core profit rises, like-for-like sales grow 20 pct